Filing Details

Accession Number:
0001217234-21-000049
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-01 16:23:29
Reporting Period:
2021-02-25
Accepted Time:
2021-03-01 16:23:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1217234 Caredx Inc. CDNA Services-Medical Laboratories (8071) 943316839
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1688485 Reginald Seeto C/O Caredx, Inc.
1 Tower Place, 9Th Floor
South San Francisco CA 94080
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-25 20,000 $0.00 161,788 No 4 A Direct
Common Stock Disposition 2021-02-25 8,450 $79.26 153,338 No 4 F Direct
Common Stock Disposition 2021-03-01 300 $82.35 153,038 No 4 S Direct
Common Stock Disposition 2021-03-01 600 $83.32 152,438 No 4 S Direct
Common Stock Disposition 2021-03-01 1,200 $84.55 151,238 No 4 S Direct
Common Stock Disposition 2021-03-01 6,504 $85.64 144,734 No 4 S Direct
Common Stock Disposition 2021-03-01 2,100 $86.45 142,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported securities were represented by restricted performance stock units that were granted on February 3, 2020, 100% of which vested on February 25, 2021 upon the achievement of the requisite performance criteria.
  2. These shares remain subject to a lock-up agreement entered into among the Reporting Person and the representatives of the underwriters for the Issuer's public offering of common stock completed in January 2021.
  3. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
  4. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2020.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.76 to $82.735, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.915 to $83.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.98 to $84.975, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.17 to $86.15, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.205 to $86.875, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.